Answers are grounded in this paper and cite their sources.
Type 1.5 diabetes (1) is characterized by rapid loss of β-cell function, failure of oral agents, and acquirement of insulin requirement (2,3). These patients have islet cell antibodies (ICAs), GAD65 autoantibodies (GAD65Abs) (4,5,6), or both, indicating an underlying autoimmune pathogenesis. Therefore, the question of whether type 1.5 diabetes represents a separate clinical disease or a slowly progressive form of type 1 diabetes has been raised (7,8). The aim of the present study was to investigate whether GAD65Ab epitopes in type 1.5 diabetic patients differ from those found in type 1 diabetic patients and other GAD65Ab-positive phenotypes. Type 1.5 diabetic patients ( n = 34) were identified as GAD65Ab-positive type 2 diabetic …
No takes yet. Share an insight, caveat, or question.
Hampe et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: